SUMMIT MAX: A randomized trial of the super large bore HiPoint Reperfusion System versus Vecta System for aspiration thrombectomy.
Nguyen TN, Dabus G, McGuinness B, Caldwell J, Priest R, Rai A, Zaidat OO, Gross BA, Hanel RA, Lee SSH, Hussain MS, Shaikh H, Abdalkader M, Budzik RF, Kilburg C, Woodward BK, Colasurdo M, Liu J, Yoo AJ, Khandelwal P, Boo S, Vu P, Lin E, AlMajali M, Singh J, Al-Bayati AR, Lang MJ, Abraham MG, Hassan AE, Pema P, Martin CO, Grandhi R, Tonetti DA, Hixson HR, Aghaebrahim A, Sauvageau E, Ortega-Gutierrez S, Yavagal DR, Cheng-Ching E, Khalife J, Linfante I, Vulkanov V, Soomro JH, Fifi JT, Maidan L, Copelan AZ, Schirmer CM, Bain M, Toth G, Jayaraman MV, Novakovic-White R, Satti SR, Villelli N, Jabbour PM, Page M, Mcallister DJ, Araujo Contreras R, Samaniego EA, Liebeskind DS, Hetts SW, Nogueira RG, English J, Puri AS. SUMMIT MAX: A randomized trial of the super large bore HiPoint Reperfusion System versus Vecta System for aspiration thrombectomy. Stroke. 2025 May 21.